BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $229,362 | +4.8% | 5,034 | -6.7% | 0.03% | 0.0% |
| Q1 2023 | $218,776 | -62.5% | 5,394 | -52.9% | 0.03% | -64.4% |
| Q4 2022 | $583,941 | +65.0% | 11,457 | +74.5% | 0.07% | +52.1% |
| Q3 2022 | $354,000 | +1.1% | 6,567 | +20.5% | 0.05% | +2.1% |
| Q2 2022 | $350,000 | -10.7% | 5,449 | +7.9% | 0.05% | 0.0% |
| Q1 2022 | $392,000 | -9.7% | 5,051 | +0.0% | 0.05% | -9.6% |
| Q4 2021 | $434,000 | +11.6% | 5,049 | +4.4% | 0.05% | +6.1% |
| Q3 2021 | $389,000 | +12.1% | 4,838 | +12.1% | 0.05% | +6.5% |
| Q2 2021 | $347,000 | -5.4% | 4,317 | -0.8% | 0.05% | -14.8% |
| Q1 2021 | $367,000 | +6.4% | 4,351 | +1.6% | 0.05% | 0.0% |
| Q4 2020 | $345,000 | +6.5% | 4,281 | +6.7% | 0.05% | -5.3% |
| Q3 2020 | $324,000 | -3.9% | 4,012 | +11.4% | 0.06% | -9.5% |
| Q2 2020 | $337,000 | +5.3% | 3,600 | -0.8% | 0.06% | -8.7% |
| Q1 2020 | $320,000 | -17.1% | 3,628 | -16.3% | 0.07% | -1.4% |
| Q4 2019 | $386,000 | +10.9% | 4,332 | +1.1% | 0.07% | +1.4% |
| Q3 2019 | $348,000 | -3.3% | 4,286 | -2.9% | 0.07% | -5.5% |
| Q2 2019 | $360,000 | +291.3% | 4,414 | +289.9% | 0.07% | +217.4% |
| Q1 2019 | $92,000 | +31.4% | 1,132 | +6.0% | 0.02% | +21.1% |
| Q4 2018 | $70,000 | -14.6% | 1,068 | +0.1% | 0.02% | -13.6% |
| Q3 2018 | $82,000 | +3.8% | 1,067 | 0.0% | 0.02% | -4.3% |
| Q2 2018 | $79,000 | +16.2% | 1,067 | 0.0% | 0.02% | +15.0% |
| Q1 2018 | $68,000 | -8.1% | 1,067 | 0.0% | 0.02% | -16.7% |
| Q4 2017 | $74,000 | +12.1% | 1,067 | 0.0% | 0.02% | +9.1% |
| Q3 2017 | $66,000 | +1.5% | 1,067 | 0.0% | 0.02% | -12.0% |
| Q2 2017 | $65,000 | +22.6% | 1,067 | +6.2% | 0.02% | -7.4% |
| Q1 2017 | $53,000 | +12.8% | 1,005 | 0.0% | 0.03% | -6.9% |
| Q4 2016 | $47,000 | -2.1% | 1,005 | 0.0% | 0.03% | +26.1% |
| Q3 2016 | $48,000 | +4.3% | 1,005 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $46,000 | – | 1,005 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
| THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
| SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
| Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
| 13D Management LLC | 194,807 | $11,794,000 | 4.18% |
| Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
| Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
| Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
| PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |